LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC

Annals of Oncology ◽

10.1016/j.annonc.2021.10.217 ◽

2021 ◽

Vol 32 ◽

pp. S1428

Author(s):

B.C. Cho ◽

D. Rodriguez-Abreu ◽

M. Hussein ◽

M. Cobo ◽

A. Patel ◽

...

Keyword(s):

Phase Ii ◽

Patient Reported Outcomes ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

Patient Reported ◽

First Line Treatment

Download Full-text

A comparative randomized, placebo-controlled, double-blind phase II study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment for advanced ovarian cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.5010 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 5010-5010

Author(s):

I. B. Vergote ◽

P. Harter ◽

N. Kovalenko ◽

T. Bauknecht ◽

K. Mansouri ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726641973.793540485 ◽

2017 ◽

Author(s):

Lori Ann Birder

Keyword(s):

Overactive Bladder ◽

Phase Ii ◽

Combination Treatment ◽

Patient Reported Outcomes ◽

Phase Ii Study ◽

Double Blind ◽

Patient Reported ◽

Dose Ranging

Download Full-text

Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.2003.13039.x ◽

2003 ◽

Vol 13 (2) ◽

pp. 130-137 ◽

Cited By ~ 9

Author(s):

T. Bauknecht ◽

A. Hefti ◽

G. Morack ◽

C. Villena-Heinsen ◽

D. Wallwiener ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00110-2 ◽

2021 ◽

Author(s):

Arndt Vogel ◽

Shukui Qin ◽

Masatoshi Kudo ◽

Yun Su ◽

Stacie Hudgens ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Patient Reported Outcomes ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Phase 3 ◽

Unresectable Hepatocellular Carcinoma ◽

Carcinoma Patient ◽

Patient Reported ◽

First Line Treatment

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Cited By ~ 4

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: A phase II study

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.06.013 ◽

2005 ◽

Vol 23 (5) ◽

pp. 381-382

Author(s):

Donald L. Trump

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Advanced Urothelial Carcinoma ◽

First Line Treatment

Download Full-text

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2014.12.020 ◽

2015 ◽

Vol 51 (4) ◽

pp. 473-481 ◽

Cited By ~ 10

Author(s):

Maria Di Bartolomeo ◽

Andrea Ciarlo ◽

Alessandro Bertolini ◽

Sandro Barni ◽

Claudio Verusio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Medical Oncology ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

European Urology ◽

10.1016/j.eururo.2007.02.060 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1020-1027 ◽

Cited By ~ 13

Author(s):

Giuseppe Di Lorenzo ◽

Riccardo Autorino ◽

Sisto Perdonà ◽

Michele De Laurentiis ◽

Massimo D'Armiento ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Hormone Refractory Prostate Cancer ◽

Line Treatment ◽

First Line ◽

Hormone Refractory ◽

First Line Treatment

Download Full-text

1652P A prospective, single-arm phase II study of pegylated-liposome doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1878 ◽

2020 ◽

Vol 31 ◽

pp. S986

Author(s):

X. Liu ◽

X. Zhang ◽

J. Cao ◽

H. Wang ◽

X. Wu ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Pegylated Liposome ◽

Metastatic Soft Tissue Sarcoma ◽

First Line Treatment

Download Full-text